Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Placebo-controlled trials: when are they needed?

D L Streiner1

  • 1Department of Clinical Epidemiology, McMaster University, Hamilton, Ont., Canada. streiner@fhs.csu.mcmaster.ca

Schizophrenia Research
|March 27, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Objective and subjective vasomotor symptom outcomes in the CBT-Meno randomized controlled trial.

Climacteric : the journal of the International Menopause Society·2020
Same author

Validation of MRI predictors of multiple sclerosis diagnosis in children with acute CNS demyelination.

Multiple sclerosis and related disorders·2015
Same author

Development of a standardized MRI scoring tool for CNS demyelination in children.

AJNR. American journal of neuroradiology·2013
Same author

The trajectory of recovery and the inter-relationships of symptoms, activity and participation in the first year following total hip and knee replacement.

Osteoarthritis and cartilage·2011
Same author

Sore throats in adults: who sees a doctor?

Canadian family physician Medecin de famille canadien·2011
Same author

Quality of life in childhood epilepsy: what is the level of agreement between youth and their parents?

Epilepsy & behavior : E&B·2009
Same journal

Weight loss and gut microbial changes associated with semaglutide among people living with schizophrenia receiving clozapine or olanzapine: An open-label 24-week semaglutide intervention and 76-week trial.

Schizophrenia research·2026
Same journal

Converting negative symptom dimension scores across SANS and PANSS.

Schizophrenia research·2026
Same journal

Inflammation-associated alterations in mGluR transcript expression in the human nucleus accumbens independent of schizophrenia diagnosis.

Schizophrenia research·2026
Same journal

One social interaction after another: Dynamic modeling of social experience in schizophrenia.

Schizophrenia research·2026
Same journal

Reduced synaptic plasticity and E/I imbalance drive peripersonal space boundaries expansion in schizophrenia.

Schizophrenia research·2026
Same journal

Complete blood count-derived inflammatory markers and symptom phenotypes in schizophrenia spectrum disorders: A hierarchical clustering analysis.

Schizophrenia research·2026
See all related articles

Randomized controlled trials may not need placebo controls if well-designed. Alternative methods and strict ethical guidelines can ensure valid results, minimizing bias in clinical research.

Area of Science:

  • Clinical Trials
  • Medical Research Ethics

Background:

  • Randomized controlled trials (RCTs) assign participants to treatment or control groups.
  • Control arms may use placebos, active drugs, or conventional treatments.

Purpose of the Study:

  • To explore the necessity and implications of placebo controls in RCTs.
  • To identify strategies for minimizing reliance on placebo arms while ensuring trial validity.

Main Methods:

  • Analysis of interpretation challenges in RCTs lacking placebo controls.
  • Discussion of potential biases and errors (e.g., Type II errors) in such studies.
  • Proposal of ethical safeguards and design modifications when placebo use is necessary.

Main Results:

  • Lack of statistically significant differences in trials without placebos can be ambiguous.
Keywords:
Biomedical and Behavioral ResearchMental Health Therapies

Related Experiment Videos

  • Ambiguity arises from equal treatment effectiveness versus study design flaws or low statistical power.
  • External review and specific ethical conditions can mitigate risks associated with placebo use.

    • Conclusions:

    • Placebo controls in RCTs may be minimized with robust study design and execution.
    • Strict ethical protocols, including informed consent and external monitoring, are crucial if placebos are used.
    • Alternative randomization strategies warrant further investigation to enhance clinical trial validity.